Mydecine Innovations Group

Vancouver, Canada

Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders.

$3.8M raised

Sep 2023

Post-IPO Equity

Biotechnology Life Science Mental Health Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Mydecine Innovations Group

How much funding has Mydecine Innovations Group raised?

Mydecine Innovations Group has raised $3.8M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2023.

Where is Mydecine Innovations Group headquartered?

Mydecine Innovations Group is headquartered in Vancouver, Canada.

What does Mydecine Innovations Group do?

Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders.

What stage is Mydecine Innovations Group at?

Mydecine Innovations Group is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 15, 2023.

MLA

"Mydecine Innovations Group — Funding & Investors." VCBacked, September 15, 2023, https://www.vcbacked.co/company/mydecine-innovations-group. Accessed July 2, 2026.

APA

VCBacked. (2023). Mydecine Innovations Group — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/mydecine-innovations-group

Wikipedia (cite web)

{{cite web |title=Mydecine Innovations Group — Funding & Investors |url=https://www.vcbacked.co/company/mydecine-innovations-group |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 15, 2023.